Abstract
Ascidians (tunicates) are widely recognized as one of the most prolific producers of bioactive natural products in the marine environment. In particular, ascidians of the genus Aplidium are renowned for the variability in the metabolites that they content. The non-nitrogenous compounds are dominated by the presence of meroterpenoids exemplified by the longithorones. Among the nitrogen containing group, nucleosides, cyclic peptides and a high variety of alkaloids can be mentioned. In this review the most interesting aspects of structure elucidation and bioactivity of the natural products from species of the genus Aplidium reported up to the end of 2004 will be presented.
Keywords: natural products, marine metabolites, ascidians, tunicates, aplidium
Mini-Reviews in Organic Chemistry
Title: Natural Products Chemistry in Marine Ascidians of the Genus Aplidium
Volume: 2 Issue: 4
Author(s): Eva Zubia, Maria J. Ortega and Javier Salva
Affiliation:
Keywords: natural products, marine metabolites, ascidians, tunicates, aplidium
Abstract: Ascidians (tunicates) are widely recognized as one of the most prolific producers of bioactive natural products in the marine environment. In particular, ascidians of the genus Aplidium are renowned for the variability in the metabolites that they content. The non-nitrogenous compounds are dominated by the presence of meroterpenoids exemplified by the longithorones. Among the nitrogen containing group, nucleosides, cyclic peptides and a high variety of alkaloids can be mentioned. In this review the most interesting aspects of structure elucidation and bioactivity of the natural products from species of the genus Aplidium reported up to the end of 2004 will be presented.
Export Options
About this article
Cite this article as:
Zubia Eva, Ortega J. Maria and Salva Javier, Natural Products Chemistry in Marine Ascidians of the Genus Aplidium, Mini-Reviews in Organic Chemistry 2005; 2 (4) . https://dx.doi.org/10.2174/157019305774322707
DOI https://dx.doi.org/10.2174/157019305774322707 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Self-Assembling Peptides: Potential Role in Tumor Targeting
Current Pharmaceutical Biotechnology Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs
Current Neuropharmacology microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Melatonin a Promising Candidate for DNA Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations
Anti-Cancer Agents in Medicinal Chemistry Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Role of Active Drug Transporters in Refractory Multiple Myeloma
Current Topics in Medicinal Chemistry Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition The Role of CXC-Chemokine IL-8, IL-6 and CXCR2 Receptor in Lymphoplasmacytic Lymphoma: Correlations with Microvascular Characteristics and Clinical Features
Current Angiogenesis (Discontinued) Epigenetic Regulation of ABCB1 Transporter Expression and Function
Current Pharmacogenomics and Personalized Medicine Tubulin Inhibitors: A Patent Survey
Recent Patents on Anti-Cancer Drug Discovery Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
Current Pharmaceutical Design Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)
Current Pharmaceutical Design Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research
Current Medicinal Chemistry The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer
Current Cancer Drug Targets The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Current Pharmaceutical Design SYNTHESIS AND APPLICATIONS OF Fe3O4/SiO2 CORE-SHELL MATERIALS
Current Pharmaceutical Design Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets